GlaxoSmithKline, Teva, Takeda Investing in Global Sustainability Performance with the Responsible Health Initiative

February 6, 2019 EcoVadis ‏‏‎


Three leading health and pharmaceutical companies -- GlaxoSmithKline, Teva, Takeda – and EcoVadis, the leading provider of sustainability risk and performance ratings for global supply chains, today announced the launch of the Responsible Health Initiative. The mission of the new sector initiative is to use collaboration and technology to improve the visibility, efficiency and sustainability impact of the global health supply chain.


About the Author

EcoVadis ‏‏‎

EcoVadis is the world’s most trusted provider of business sustainability ratings, intelligence and collaborative performance improvement tools for global supply chains. Backed by a powerful technology platform and a global team of domain experts, EcoVadis’ easy-to-use and actionable sustainability scorecards provide detailed insight into environmental, social and ethical risks across 198 purchasing categories and 155 countries.

Follow on Twitter Follow on Linkedin Visit Website More Content by EcoVadis ‏‏‎
Previous Article
Improving the Lot of the Global Supply-Chain Worker
Improving the Lot of the Global Supply-Chain Worker

EcoVadis is another entity to employ technology to monitor factory conditions. It provides an online platfo...

Next Article
Less Than 10 Percent of Global Companies Report on Business Ethics KPIs, According to New EcoVadis Anti-Corruption Report
Less Than 10 Percent of Global Companies Report on Business Ethics KPIs, According to New EcoVadis Anti-Corruption Report

EcoVadis has published a new anti-corruption study that reports how businesses manage critical ethical issu...